// startup autopsy

BT Pharma

Prescribing software solutions to a market that wasn't ready to take the medicine.

marketfitSilent Shutdown

Quiet closure with no public announcement · Fatal mistake: Attempted to sell SaaS software into the heavily regulated pharmaceutical industry without the capital runway required to survive long enterprise sales cycles.

Founded	2005
Closed	2008
Country	USA
Sector	Healthtech

50%

Key Events Timeline

2005-01-01

FOUNDING

BT Pharma founded to deliver SaaS solutions to the pharmaceutical industry.

2007-06-01

FUNDING

Raised approximately $1.75M in what appears to be its last funding round.

2007-12-01

PRODUCT LAUNCH

Attempted to scale product adoption within pharma enterprises but faced long compliance-driven sales cycles.

2008-06-01

SHUTDOWN

Company closed operations after failing to generate sufficient revenue in the regulated pharma software market.

Full Analysis

Analyst plan

Documented cause

BT Pharma was a pharmaceutical SaaS startup that failed due to a combination of insufficient capitalization and misalignment between its business model and market dynamics. With only ~$1.75M in funding, the com...

pany lacked the capital necessary to compete in the highly regulated pharmaceutical software market, where enterprise sales cycles are notoriously long (12-24+ months) and customer acquisition costs a

Verified lesson

“...”

Unlock full lesson →

€7M

Peak valuation

HypeCycle · MoatType · ResearchTags

BT Pharma raised €1.7483457959008M before attempted to sell saas software into the heavily regulated pharmaceutical industry without the capital runway required to survive long enterprise sales cycles. ended it. See the documented cause, verified lesson and all failure signals.

Unlock full analysis →Create free account

See all plans·Analyst plan — €149/mo